Kimberly Pardo, listed as an investor in LifeStance Health Group, Inc., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 2,216,585 shares of LifeStance common stock with an aggregate market value of $31,918,824, to be executed through Merrill Lynch Pierce Fenner & Smith on NASDAQ.

Key Highlights

  • Proposed sale size: 2,216,585 shares of LifeStance Health Group common stock with an aggregate market value of $31,918,824, according to the filing.
  • Seller: Kimberly Pardo, identified as an investor; the filing notes the shares are to be sold in the Kimberly Pardo Irrevocable Trust.
  • Approximate sale date: November 10, 2026, through broker Merrill Lynch Pierce Fenner & Smith, Burlington, MA.
  • Shares outstanding: The filing states 380,190,724 shares of common stock outstanding at the time of the notice.
  • Rule 10b5-1 plan: The notice indicates a trading plan or instruction date of August 11, 2026.
  • Prior 3-month sales: The filing reports nothing to report for securities sold during the past 3 months.
  • Acquisition history: The shares were acquired through four separate private placement transactions from the issuer, dated June 14, 2021; June 3, 2022; May 14, 2023; and April 1, 2024, all paid in cash.

Pardo's Proposed LifeStance Share Sale: Acquisition Background and Sale Details

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Kimberly Pardo intends to sell 2,216,585 shares of common stock in LifeStance Health Group, Inc. (NASDAQ:LFST), with an aggregate market value listed as $31,918,824. The filing identifies Pardo's relationship to the issuer as "investor." The proposed sale is to be conducted through Merrill Lynch Pierce Fenner & Smith, with a broker address at 25 Burlington Mall Road, Burlington, MA 01803, and is listed on NASDAQ.

The filing discloses four separate private placement transactions from which the shares being proposed for sale were acquired. Those acquisitions, all from the issuer and all paid in cash, occurred on June 14, 2021 (558,087 shares), June 3, 2022 (1,100,411 shares), May 14, 2023 (223,250 shares), and April 1, 2024 (334,837 shares). The combined total of those four acquisition lots equals the 2,216,585 shares proposed for sale.

The filing's remarks section states that the shares are to be sold in the "Kimberly Pardo Irrev Trust." Pardo indicated reliance on Rule 10b5-1, with a plan adoption or instruction date of August 11, 2026. No sales were reported for the three-month period preceding the notice date. The filing was dated November 10, 2026, and LifeStance Health Group, Inc. is headquartered at 4800 North Scottsdale Rd, Suite 2500, Scottsdale, Arizona 85251.

What Was Disclosed

Kimberly Pardo filed a Form 144 notice disclosing a proposed sale of 2,216,585 LifeStance Health Group common shares, valued at $31,918,824 in aggregate, to be sold through Merrill Lynch Pierce Fenner & Smith under a Rule 10b5-1 plan adopted August 11, 2026, with no sales reported in the prior three months.